// App-Quantinova.ai

BSH2020‐EP‐070 : Local experience of the use of IVE methotrexate chemotherapy for the treatment of systemic T‐cell lymphoma

Researchers

Presenter

  • T. Fail

Principal Investigators

  • W. Osborne

Medical Centers

  • Haematology, Freeman Hospital Newcastle, Newcastle Upon Tyne, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

  • Lung Cancer

  • Neutropenic Sepsis

  • Thrombocytopenia

  • T-cell lymphoma

  • Neutropenia

  • Lymphomas

  • Sepsis

Biomarkers

  • Anaplastic lymphoma Kinase

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Methotrexate

  • Vincristine

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved